Contemporary utilization of GLP1 receptor agonists and SGLT2 inhibitors in patients with diagnosed type 2 diabetes and cardiovascular disease in the United States.
作者信息
Al-Kindi Sadeer G, Janus Scott E, Neeland Ian J, Rajagopalan Sanjay
机构信息
Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (CINEMA), Harrington Heart and Vascular Institute, University Hospitals, Cleveland, OH 44124, United States of America; Case Western Reserve University, Cleveland, OH, United States of America.
Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (CINEMA), Harrington Heart and Vascular Institute, University Hospitals, Cleveland, OH 44124, United States of America; Case Western Reserve University, Cleveland, OH, United States of America.
出版信息
J Diabetes Complications. 2022 Jul;36(7):108224. doi: 10.1016/j.jdiacomp.2022.108224. Epub 2022 Jun 1.
Abstract
摘要
Zotero 插件